Welcome: Guest | Site Use Options | Register | Login |

712 North Inc

712 North Inc

Profile last edited on: 5/14/2020
1814 23rd Street
San Francisco, CA 94107
  (415) 489-8995
Business Identifier: Personalized mitochondrial medicines
Public Profile:
712 North is a pre-clinical stage pharmaceutical company structured around development of modulators of the dynamic mitochondrial network for a range of age-related diseases: Alzheimer's, cancer, glaucoma, and cardiovascular disease. The mechanism of action also ties the biology to a rare pediatric indication with unmet medical need. The suggestion is that principal sof the firm may beable to leverage this orphan disease as fast to market strategy.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Discovery and Validation of OMA1 Inhibitors

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920